Literature DB >> 7875207

Precursor B cells of mouse bone marrow express two different complexes with the surrogate light chain on the surface.

T H Winkler1, A Rolink, F Melchers, H Karasuyama.   

Abstract

Two monoclonal antibodies raised against the complex of mu heavy (H) chain and Vpre-B/lambda 5 surrogate light (L) chains recognize surrogate L chain in different conformations on normal pre-B cells. One, LM34 recognizes free lambda 5 protein and free lambda 5/Vpre-B surrogate L chains and binds to surrogate L chains on the surface of early, pro-B and pre-B-I cells where the surrogate L chain is associated with a gp130/gp35-65 complex of proteins. It also recognizes the surrogate L chain associated with the mu H chain on pre-B-II cells. The other monoclonal antibody, SL156, does not recognize free surrogate L chain or its components, nor its complex with gp130/gp35-65 on pro-B and pre-B-I cells. However, it does bind to a conformational epitope on the surrogate light chain/mu H chain complex on a subpopulation of pre-B-II cells and on mu H chain-positive pre-B cell lines. On mouse precursor B cells prepared ex vivo on ice, expression of the surrogate L chain is very low and almost undetectable. Incubation of the precursor cells for 1 h at 37 degrees C up-regulates the surface expression of surrogate L chain associated with gp130/gp35-65 (early complex) as well as the mu H chain/surrogate L chain complex. These results reconcile some of the apparently discrepant results on surface expression of the surrogate L chain obtained with human and mouse bone marrow pre-B cells, and show that a surrogate L chain/mu H chain-containing pre-B cell receptor can be expressed also on the surface of mouse pre-B-II cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875207     DOI: 10.1002/eji.1830250221

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine.

Authors:  Xiuzhu Sun; Nancy Wertz; Kelly Lager; Marek Sinkora; Katerina Stepanova; Gregory Tobin; John E Butler
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

2.  Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Chiung-Chi Kuo; Joseph Haimovich; Shoshana Levy
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells.

Authors:  K Hayakawa; A M Formica; M J Colombo; S A Shinton; J Brill-Dashoff; H C Morse Iii; Y-S Li; R R Hardy
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

4.  The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells.

Authors:  K Hayashi; R Nittono; N Okamoto; S Tsuji; Y Hara; R Goitsuka; D Kitamura
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 5.  Cell circuits and niches controlling B cell development.

Authors:  Sandra Zehentmeier; João P Pereira
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

6.  The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor.

Authors:  J Ye; S K McCray; S H Clarke
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

7.  Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.

Authors:  Renren Wen; Yuhong Chen; Li Bai; Guoping Fu; James Schuman; Xuezhi Dai; Hu Zeng; Chunying Yang; Robert P Stephan; John L Cleveland; Demin Wang
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

8.  Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.

Authors:  Carolina R Batista; Michelle Lim; Anne-Sophie Laramée; Faisal Abu-Sardanah; Li S Xu; Rajon Hossain; Gillian I Bell; David A Hess; Rodney P DeKoter
Journal:  Blood Adv       Date:  2018-11-13

9.  A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

Authors:  E Meffre; F LeDeist; G de Saint-Basile; A Deville; M Fougereau; A Fischer; C Schiff
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  Two distinct populations of H chain-edited B cells show differential surrogate L chain dependence.

Authors:  Pamela B Nakajima; Kerstin Kiefer; Amy Price; Gayle C Bosma; Melvin J Bosma
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.